Rating History for Lyell Immunopharma (LYEL) by Baird
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/30/2026 | Jack Allen | New Coverage | Outperform (N/A) |
49.00 (N/A) |
20.60 (13.95) |
-32.28% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/30/2026 | Jack Allen | New Coverage | Outperform (N/A) |
49.00 (N/A) |
20.60 (13.95) |
-32.28% | Details |